| Metric | Q1 FY27 | Q4 FY26 | Q1 FY26 |
|---|---|---|---|
| Revenue from operations | 1304.1 | 1159.0 | 1030.8 |
| Other income | 22.2 | 36.7 | 20.4 |
| Total income | 1326.2 | 1195.8 | 1051.3 |
| Profit before exceptional items & tax | 213.3 | 187.3 | 188.5 |
| Exceptional items | 0.0 | 0.0 | 19.6 |
| Profit before tax | 213.3 | 187.3 | 208.1 |
| Net profit | 157.3 | 141.7 | 159.0 |
| Operating margin | 16.1% | 15.7% | 19.8% |
A dash means the filing did not report that period; n/m means not meaningful (margin on near-zero revenue). Growth is not shown when either period was a loss. Operating profit excludes other income.
| Net profit, year on year | -1.10% |
|---|---|
| Net profit, quarter on quarter | +11.00% |
| Revenue, year on year | +26.50% |
| Operating profit, year on year | -2.50% |
| Operating profit, quarter on quarter | +28.70% |
BSE results filing, NSE: MEDANTA. Figures extracted from the filing.
Global Health Ltd: key numbers
- Share price
- ₹1,495.40
- Market cap
- ₹40,208 Cr
- Revenue (annual)
- ₹4,410 Cr
- Net profit (annual)
- ₹556.5 Cr
- P/E (TTM)
- 72.3×Sector 57.8×
- Promoter holding
- 33.00%-0.01% QoQ
- FII holding
- 9.46%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Global Health Ltd
All →Global Health Employee Stock Options
Global Health Limited has allotted equity shares under its ESOP/ESPS scheme. This action results in a minor increase in the company's total paid-up share capital.
Global Health Employee Stock Options
Global Health Limited has allotted 3,000 equity shares under its employee stock option plan at a premium of Rs. 1,498 per share.
- Value
- ₹0.45 Cr
Global Health Annual General Meeting
Global Health Limited held its 22nd Annual General Meeting on September 16, 2026. The meeting covered financial statement adoption and shareholder dividend declaration.
Global Health Investor Presentation: Key Takeaways
Global Health (Medanta) delivered Q1 FY27 revenue growth of 26% YoY to INR 13,262 million, driven by robust patient volumes and scaling of the Noida facility.
Global Health Earnings Call Transcript: Key Takeaways
Global Health (Medanta) delivered strong 26% revenue growth, fueled by higher patient volumes and a rapid turnaround in the new Noida facility.
Global Health Investor Presentation: Key Takeaways
Global Health (Medanta) reported 26.2% YoY revenue growth in Q1 FY27, driven by strong patient volumes and narrowing losses at the Noida facility.